Literature DB >> 24638881

Structure and specificity of an antibody targeting a proteolytically cleaved IgG hinge.

Thomas J Malia1, Alexey Teplyakov, Randall J Brezski, Jinquan Luo, Michelle Kinder, Raymond W Sweet, Juan C Almagro, Robert E Jordan, Gary L Gilliland.   

Abstract

The functional role of human antihinge (HAH) autoantibodies in normal health and disease remains elusive, but recent evidence supports their role in the host response to IgG cleavage by proteases that are prevalent in certain disorders. Characterization and potential exploitation of these HAH antibodies has been hindered by the absence of monoclonal reagents. 2095-2 is a rabbit monoclonal antibody targeting the IdeS-cleaved hinge of human IgG1. We have determined the crystal structure of the Fab of 2095-2 and its complex with a hinge analog peptide. The antibody is selective for the C-terminally cleaved hinge ending in G236 and this interaction involves an uncommon disulfide in VL CDR3. We probed the importance of the disulfide in VL CDR3 through engineering variants. We identified one variant, QAA, which does not require the disulfide for biological activity or peptide binding. The structure of this variant offers a starting point for further engineering of 2095-2 with the same specificity, but lacking the potential manufacturing liability of an additional disulfide. Proteins 2014; 82:1656-1667.
© 2014 Wiley Periodicals, Inc. © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  IdeS; antibody engineering; crystal structure; disulfide; hinge; proteolysis

Mesh:

Substances:

Year:  2014        PMID: 24638881     DOI: 10.1002/prot.24545

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  10 in total

1.  A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.

Authors:  Randall J Brezski; Michelle Kinder; Katharine D Grugan; Keri L Soring; Jill Carton; Allison R Greenplate; Theodore Petley; Dorie Capaldi; Kerry Brosnan; Eva Emmell; Sharon Watson; Robert E Jordan
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

2.  Evading pre-existing anti-hinge antibody binding by hinge engineering.

Authors:  Hok Seon Kim; Ingrid Kim; Linda Zheng; Jean-Michel Vernes; Y Gloria Meng; Christoph Spiess
Journal:  MAbs       Date:  2016-08-09       Impact factor: 5.857

3.  Humanization of rabbit monoclonal antibodies via grafting combined Kabat/IMGT/Paratome complementarity-determining regions: Rationale and examples.

Authors:  Yi-Fan Zhang; Mitchell Ho
Journal:  MAbs       Date:  2017-02-06       Impact factor: 5.857

4.  Generation of therapeutic immunoconjugates via Residue-Specific Conjugation Technology (RESPECT) utilizing a native cysteine in the light chain framework of Oryctolagus cuniculus.

Authors:  Earl F Albone; Jared L Spidel; Xin Cheng; Young Chul Park; Sara Jacob; Andrew Z Milinichik; Ben Vaessen; Janet Butler; J Bradford Kline; Luigi Grasso
Journal:  Cancer Biol Ther       Date:  2017-04-10       Impact factor: 4.742

5.  Tumor evasion of humoral immunity mediated by proteolytic impairment of antibody triggered immune effector function.

Authors:  Ningyan Zhang; Robert E Jordan; Zhiqiang An
Journal:  Oncoimmunology       Date:  2015-12-29       Impact factor: 8.110

6.  Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells.

Authors:  Tao Huang; Mary Mathieu; Sophia Lee; Xinhua Wang; Yee Seir Kee; Jack J Bevers; Claudio Ciferri; Alberto Estavez; Manda Wong; Nancy Y Chiang; Gerald Nakamura; Randall J Brezski
Journal:  J Biol Chem       Date:  2017-11-30       Impact factor: 5.157

Review 7.  From rabbit antibody repertoires to rabbit monoclonal antibodies.

Authors:  Justus Weber; Haiyong Peng; Christoph Rader
Journal:  Exp Mol Med       Date:  2017-03-24       Impact factor: 8.718

8.  Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions.

Authors:  Xuejun Fan; Zihao Yuan; Yueshui Zhao; Wei Xiong; Hao-Ching Hsiao; Rahmawati Pare; Jianmin Ding; Ahmad Almosa; Kai Sun; Songlin Zhang; Robert E Jordan; Cheok Song Lee; Zhiqiang An; Ningyan Zhang
Journal:  Commun Biol       Date:  2022-09-14

9.  Efficient generation of single domain antibodies with high affinities and enhanced thermal stabilities.

Authors:  Naoya Shinozaki; Ryuji Hashimoto; Kiichi Fukui; Susumu Uchiyama
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

Review 10.  Proteinase-nicked IgGs: an unanticipated target for tumor immunotherapy.

Authors:  Robert E Jordan; Xuejun Fan; Georgina Salazar; Ningyan Zhang; Zhiqiang An
Journal:  Oncoimmunology       Date:  2018-07-23       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.